Location History:
- Zürich, CH (2010)
- München, DE (2014 - 2016)
- Zurich, CH (2018)
- Martinsried, DE (2019)
- Reilingen, DE (2022)
Company Filing History:
Years Active: 2010-2022
Sure, here is an article about inventor Martin Treder:
**Title: Unveiling the Innovation Journey of Martin Treder: A Pioneer in HER-3-Related Therapeutics**
Introduction:
Martin Treder, a prolific inventor hailing from Munich, Germany, has made significant contributions to the field of molecular medicine with a focus on HER-3-related therapeutics. With an impressive portfolio of six patents, Martin's groundbreaking work has paved the way for novel diagnostic and treatment approaches for diseases associated with HER-3 mediated signal transduction.
Latest Patents:
Among his latest patents are "Antibodies directed to HER-3 and uses thereof" and "Activated HER3 as a marker for predicting therapeutic efficacy." These patents encompass the development of binding proteins targeting HER-3, along with methods for diagnosing and treating HER-3-related diseases by assessing the activation level of Receptor Tyrosine kinases, specifically phosphorylated HER3.
Career Highlights:
Martin Treder has showcased his expertise while working at renowned companies such as Amgen Inc. and U3 Pharma GmbH. His pioneering research has not only earned him recognition within the industry but has also positioned him as a key figure in advancing precision medicine approaches targeting HER receptors.
Collaborations:
Throughout his career, Martin has collaborated with esteemed professionals in the field, including coworkers like Mike Rothe and Susanne Hartmann. These collaborations have fostered a culture of innovation and knowledge-sharing, leading to impactful discoveries in the realm of molecular therapeutics.
Conclusion:
In conclusion, Martin Treder's relentless pursuit of innovation and his commitment to scientific excellence have established him as a visionary in the field of HER-3-related therapeutics. His remarkable journey serves as an inspiration for aspiring inventors and underscores the transformative power of cutting-edge research in driving advancements in healthcare.